# Werewolf Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d162107d-0e87-496a-bf93-5bde3e61fd4a | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/werewolf-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:59.013572+00:00 | | Last reviewed | 2026-10-17T04:46:59.013572+00:00 | ## Identity - Legal name: Werewolf Therapeutics, Inc. - Display name: Werewolf Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T10:14:44.392136+00:00 | | Completeness | 0.409 | | Record Quality | 0.835 | | Directors | 9 | | Committees | 3 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alon Lazarus, Ph.D.: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (chair). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:5 - Anil Singhal, Ph.D.: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:6 - Briggs Morrison, M.D.: Director. Status: current. Independent: false. Since: 2019-01-01. Committees: Audit (member). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:7 - Daniel J. Hicklin, Ph.D.: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:8 - Derek DiRocco, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Nominating/Governance (member). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:9 - Luke Evnin, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Nominating/Governance (chair). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:10 - Meeta Chatterjee, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member); Nominating/Governance (member). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:11 - Michael B. Atkins, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Nominating/Governance (member). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:12 - Michael Sherman, M.B.A.: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Compensation (member). claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:13 ## Committees - Audit (audit). Chair: Michael Sherman, M.B.A.. Members: Michael Sherman, M.B.A. (chair, current); Anil Singhal, Ph.D. (member, current); Briggs Morrison, M.D. (member, current); Derek DiRocco, Ph.D. (member, current). committee_id=alpha:committee:werewolf-therapeutics-inc:audit - Compensation (compensation). Chair: Alon Lazarus, Ph.D.. Members: Alon Lazarus, Ph.D. (chair, current); Meeta Chatterjee, Ph.D. (member, current); Michael Sherman, M.B.A. (member, current). committee_id=alpha:committee:werewolf-therapeutics-inc:compensation - Nominating/Governance (nominating_governance). Chair: Luke Evnin, Ph.D.. Members: Luke Evnin, Ph.D. (chair, current); Derek DiRocco, Ph.D. (member, current); Meeta Chatterjee, Ph.D. (member, current); Michael B. Atkins, M.D. (member, current). committee_id=alpha:committee:werewolf-therapeutics-inc:nominating-governance ## Executive leadership - Daniel J. Hicklin, Ph.D.: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:14 ## Governance events - CEO_CHANGED: Daniel J. Hicklin, Ph.D. executive of Werewolf Therapeutics, Inc., effective 2026-03-27. Effective: 2026-03-27. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1t5s3941up2h7a - DIRECTOR_APPOINTED: Anil Singhal, Ph.D. seat on Werewolf Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1307xb91vywbwl - DIRECTOR_APPOINTED: Michael B. Atkins, M.D. seat on Werewolf Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:sw5c4jrnsfnh - DIRECTOR_APPOINTED: Meeta Chatterjee, Ph.D. seat on Werewolf Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:xlvugp1w7m17 - DIRECTOR_APPOINTED: Michael Sherman, M.B.A. seat on Werewolf Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:7z5npljqqy39 - DIRECTOR_APPOINTED: Derek DiRocco, Ph.D. seat on Werewolf Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:y5047d1rt01p7 - DIRECTOR_APPOINTED: Alon Lazarus, Ph.D. seat on Werewolf Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1fk2zrfmpq8x1 - DIRECTOR_APPOINTED: Briggs Morrison, M.D. seat on Werewolf Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1gkkqcxdcpgxb - DIRECTOR_APPOINTED: Daniel J. Hicklin, Ph.D. seat on Werewolf Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:uis58ymjubfe - DIRECTOR_APPOINTED: Luke Evnin, Ph.D. seat on Werewolf Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:15tdnsb180y3bf ## Scoped resources - `alpha://company/werewolf-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record - `alpha://company/werewolf-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=identity - `alpha://company/werewolf-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/werewolf-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=board - `alpha://company/werewolf-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=committees - `alpha://company/werewolf-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=leadership - `alpha://company/werewolf-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=ownership - `alpha://company/werewolf-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=financials - `alpha://company/werewolf-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/werewolf-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=compensation - `alpha://company/werewolf-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=governance - `alpha://company/werewolf-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/werewolf-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=audit - `alpha://company/werewolf-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=legal - `alpha://company/werewolf-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=risk - `alpha://company/werewolf-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=cyber - `alpha://company/werewolf-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/werewolf-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=agents - `alpha://company/werewolf-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/werewolf-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=events - `alpha://company/werewolf-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=relationships - `alpha://company/werewolf-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=assessments - `alpha://company/werewolf-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:michael-sherman-m-b-a","name":"Michael Sherman, M.B.A."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:anil-singhal-ph-d","name":"Anil Singhal, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:briggs-morrison-m-d","name":"Briggs Morrison, M.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:derek-dirocco-ph-d","name":"Derek DiRocco, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:alon-lazarus-ph-d","name":"Alon Lazarus, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:meeta-chatterjee-ph-d","name":"Meeta Chatterjee, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-sherman-m-b-a","name":"Michael Sherman, M.B.A."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating/Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:luke-evnin-ph-d","name":"Luke Evnin, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating/Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:derek-dirocco-ph-d","name":"Derek DiRocco, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating/Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:meeta-chatterjee-ph-d","name":"Meeta Chatterjee, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating/Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:michael-b-atkins-m-d","name":"Michael B. Atkins, M.D."},"source_id":"governance_people_committees"}` ## Leadership - Alon Lazarus, Ph.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Anil Singhal, Ph.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Briggs Morrison, M.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Daniel J. Hicklin, Ph.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:8. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Derek DiRocco, Ph.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Luke Evnin, Ph.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Meeta Chatterjee, Ph.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Michael B. Atkins, M.D.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Michael Sherman, M.B.A.: Director. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:13. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6. - Daniel J. Hicklin, Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:leadership_role:14. Valid from: 2026-03-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1151d3fe3328abbdf9083a4ac3fc6b0425146bea7844f50c1097c588fc863bab. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Michael Sherman, M.B.A.; Members Michael Sherman, M.B.A. (Chair); Anil Singhal, Ph.D.; Briggs Morrison, M.D.; Derek DiRocco, Ph.D.. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Compensation: Chair Alon Lazarus, Ph.D.; Members Alon Lazarus, Ph.D. (Chair); Meeta Chatterjee, Ph.D.; Michael Sherman, M.B.A.. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Nominating/Governance: Chair Luke Evnin, Ph.D.; Members Luke Evnin, Ph.D. (Chair); Derek DiRocco, Ph.D.; Meeta Chatterjee, Ph.D.; Michael B. Atkins, M.D.. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Werewolf Therapeutics, Inc.. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ec9408d89345f876d76b8b1e1dd45f56119cd61a125cefef39b3253b7495ac3. ## Entity Status - Public listing published. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ec9408d89345f876d76b8b1e1dd45f56119cd61a125cefef39b3253b7495ac3. ## Published Fact - US. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ec9408d89345f876d76b8b1e1dd45f56119cd61a125cefef39b3253b7495ac3. ## Committee Appointment - Michael Sherman, M.B.A.: chair, Audit. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Anil Singhal, Ph.D.: member, Audit. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Briggs Morrison, M.D.: member, Audit. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Derek DiRocco, Ph.D.: member, Audit. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Alon Lazarus, Ph.D.: chair, Compensation. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Meeta Chatterjee, Ph.D.: member, Compensation. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Michael Sherman, M.B.A.: member, Compensation. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Luke Evnin, Ph.D.: chair, Nominating/Governance. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Derek DiRocco, Ph.D.: member, Nominating/Governance. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Meeta Chatterjee, Ph.D.: member, Nominating/Governance. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. - Michael B. Atkins, M.D.: member, Nominating/Governance. Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c. ## Security Listing - HOWL (NASDAQ). Claim: alpha:claim:company:d162107d-0e87-496a-bf93-5bde3e61fd4a:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ec9408d89345f876d76b8b1e1dd45f56119cd61a125cefef39b3253b7495ac3. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:4ec9408d89345f876d76b8b1e1dd45f56119cd61a125cefef39b3253b7495ac3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/werewolf-therapeutics-inc). - alpha:projection-evidence:document:ebb6e4c2c6d5f5d0e8a6d16307be3ecfa5e6f8ca2a611e0e9a78826a633b27d6: [Werewolf Therapeutics, Inc. DEF 14A 2025-04-28](https://www.sec.gov/Archives/edgar/data/1785530/000114036125015885/ny20042816x1_def14a.htm). - alpha:projection-evidence:document:1151d3fe3328abbdf9083a4ac3fc6b0425146bea7844f50c1097c588fc863bab: [HOWL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1785530/000178553026000006/howl-20251231.htm). - alpha:projection-evidence:50126375025af9807f5d8ba701883e822d41edc104afa2a3642683fabc74812c: [Audit](https://www.sec.gov/Archives/edgar/data/1785530/000114036125015885/ny20042816x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/werewolf-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/werewolf-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/werewolf-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/werewolf-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T10:14:44.19938+00:00; recorded 2026-10-17T10:14:44.19938+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.